Large-scale genomic dataset analyses demonstrated that the synergistic effect of MUC4, MUC16, and MUC20 was linked to a statistically significant reduction in OS and elevated HR in colon, stomach, and pancreatic cancers [9]. This evidence concerns the gene MUC20 and pancreatic neoplasm.